Empagliflozin (EMPA) Enhances Vascular Insulin Sensitivity and Lowers Plasma ICAM in Subjects with Type 2 Diabetes (T2D)

被引：0
|
作者：
Nguyen, Thi
Jahn, Linda
Hartline, Lee
Aylor, Kevin W.
Barrett, Eugene
机构：
来源：
DIABETES | 2023年 / 72卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.2337/db23-1784-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1784-PUB
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Empagliflozin (EMPA) Improves Vascular Insulin Sensitivity and Enhances Skeletal and Cardiac Muscle Microvascular Perfusion in Persons with Type 2 Diabetes
    Jahn, Linda
    Hartline, Lee
    Aylor, Kevin W.
    Horton, William B.
    Barrett, Eugene
    DIABETES, 2023, 72
  • [2] Sodium Glucose Cotransporter 2 (SGLT2) Inhibition with Empagliflozin (EMPA) Reduces Microalbuminuria in Patients with Type 2 Diabetes (T2D)
    Cherney, David
    Von Eynatten, Maximilian
    Lund, Soeren
    Kaspers, Stefan
    Crowe, Suzanne
    Woerle, Hans J.
    Hach, Thomas
    DIABETES, 2014, 63 : A293 - A293
  • [3] Insulin Sensitivity and Hyperfiltration in Adolescents with Type 2 Diabetes (T2D) in the TODAY Clinical Trial
    Bjornstad, Petter
    Laffel, Lori M.
    Arslanian, Silva A.
    Bacha, Fida
    El Ghormli, Laure
    Libman, Ingrid
    Mandalapu, Rathna
    Mckay, Siripoom V.
    Nehus, Edward J.
    Willi, Steven M.
    Nadeau, Kristen J.
    DIABETES, 2016, 65 : A138 - A138
  • [4] LIVRQNac (AXA 1125) Enhances Insulin Sensitivity in Primary Human Hepatocytes and in Subjects with NAFLD and T2D
    Baum, Seth
    Harrison, Stephen A.
    Gunn, Nadege T.
    Younes, Ziad
    Kohli, Anita
    Patil, Rashmee
    Frias, Juan P.
    Hamill, Michael
    Daou, Nadine
    Zhao, Jeff
    Chakravarthy, Manu
    Koziel, Margaret
    DIABETES, 2021, 70
  • [5] The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in patients with Type 2 diabetes (T2D)
    Kotsa, K
    Papazisi, A
    Spanopoulos, I
    Giovos, I
    DIABETOLOGIA, 2004, 47 : A221 - A222
  • [6] Empagliflozin improves vascular insulin sensitivity and muscle perfusion in persons with type 2 diabetes
    Jahn, Linda A.
    Hartline, Lee M.
    Nguyen, Thi
    Aylor, Kevin
    Horton, William B.
    Liu, Zhenqi
    Barrett, Eugene J.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2024, 326 (03): : E258 - E267
  • [7] Design of the Empagliflozin Cardiovascular (CV) Outcome Event Trial in Type 2 Diabetes (T2D)
    Zinman, Bernard
    Inzucchi, Silvio E.
    Lachin, John M.
    Wanner, Christoph
    Ferrari, Roberto
    Bluhmki, Erich
    Hantel, Stefan
    Johansen, Odd Erik
    Woerle, Hans-Juergen
    Broedl, Uli C.
    DIABETES, 2013, 62 : A600 - A600
  • [8] Albiglutide Signifi cantly Lowers Glycemia in Japanese Patients With Type 2 Diabetes (T2D)
    Seino, Yutaka
    Inagaki, Nobuya
    Miyahara, Hajime
    Okuda, Inaha
    Bush, Mark
    Yang, Fred
    Ye, June
    Holland, Claire
    Johnson, Susan
    Lewis, Eric
    Nakajima, Hiromu
    DIABETES, 2012, 61 : A248 - A248
  • [9] Aleglitazar (ALE) Improves Insulin Sensitivity, Glucose Control, and Lipids in People with Type 2 Diabetes (T2D)
    Stirban, Alin O.
    Andjelkovic, Mirjana
    Heise, Tim
    Nosek, Leszek
    Fischer, Annelie
    Gastaldelli, Amalia
    Herz, Matthias
    DIABETES, 2014, 63 : A291 - A291
  • [10] Inflammatory and Apoptotic Markers in Plasma and Renal Function in Subjects with Type 2 Diabetes (T2D) and without Proteinuria
    Gohda, Tomohito
    Niewczas, Monika A.
    Walker, William H.
    Crabtree, Gordon S.
    Burman, Aaron M.
    Smiles, Adam M.
    Warram, James H.
    Krolewski, Andrzej S.
    DIABETES, 2009, 58 : A215 - A215
12345